Table 2.
Effects of Surgery Compared to Placebo or No Treatment
| LAUP Ferguson et al., 200317 | LAUP Larossa et al., 200419 | TCRAFTA Woodson et al., 200318 | TCRAFTA Stuck et al., 200520 | |
|---|---|---|---|---|
| ESS | −2.2 (−15, 9.3) | −0.4 (−13, 12) | −1.2 (−3.1, 0.8) | −0.6 (−1.2, 2.3) |
| FOSQ | −0.9 (−0.1, 1.9) | |||
| SAQLI | 0.2 (−0.6, 1.0) | |||
| SF-36 Physical | 1.4 (−38, 41) | −1.0 (−5.1, 3.1) | ||
| SF-36 Mental | −2 (−49, 45) | 2.5 (−1.4, 6.4) | ||
| AHI | −10.5, P = 0.04 | 7 (−76, 90) | −2.7 (−9.9, 4.5) | |
| Snoring intensity | −4.0 (−5.5, −2.5)* | −1.1 (−12, 10) | ||
| Snoring frequency | −3.6 (−1.3, −5.9)* | −106 (−8753, 8541) | ||
| Snoring subjective | −0.5 (−3.8, 2.8) | −2.5 (−4.6, −0.4)* |
*
Significant as 0 was not included in the confidence interval.
Abbreviations: LAUP, laser-assisted uvulopalatoplasty; TCRAFTA, temperature-controlled radiofrequency tissue ablation; ESS, Epworth sleepiness scale; NS, No significant change. SF36 Short Form 36; FOSQ, functional outcome of sleep questionnaire; SAQLI, Calgary Sleep Apnea Quality of Life Index; AHI, Apnea-hypopnea index